Search companies

Live

Wednesday, 18 November 2026 · 635 Summaries Today

S&P/ASX 200 · 8,821.80 (-0.69%)

Bubs Wins Permanent FDA Authorisation as US Retail Sales Surge

Bubs Australia Limited (BUB) · Consumer staples

BUB: $0.082 -7.87% · MC: $71M

Bubs Australia secured permanent FDA authorisation for three infant formula products, while US retail scan sales rose 46.5% year on year and 10.6% from the previous quarter as distribution expanded to more than 12,000 stores. Quarterly net revenue fell 9.8% year on year to approximately $23 million, and operating cash outflow increased to $6 million; available liquidity was $13 million at quarter-end.

Source announcements: 2026-10-29 08:21 to 2026-10-29 08:21 Sydney time
Story updated 2026-10-29 10:53 Sydney time
SourcesQuarterly Activities/Appendix 4C Cash Flow Report
Comments